HRMY - Harmony Biosciences Holdings Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Global Market Current Price & Safety Score Price: 38.50 USD StockBonds Safety Grade: A+ Altman Z-Score (Bankruptcy Risk): 5.63 StockBond Score: 0.79 Company Description Harmony Biosciences Holdings Inc is a commercialstage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions Their flagship product WAKIX is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy The company which was founded in 2017 was formerly known as Harmony Biosciences II Inc before adopting its current name in February 2020 Harmony Biosciences Holdings Inc operates out of Plymouth Meeting Pennsylvania